Diabetes technology

Decision accuracy of simultaneously used real‐time continuous glucose monitoring (CGM) versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI ‐1 study

Diabet MedPublished Secondary analysis of the ULTRAFLEXI-1 study

Authors' conclusion

In this head-to-head comparison of rtCGM and isCGM, isCGM demonstrated superior performance during exercise in adults with T1D.

Study context

Population
People with T1D (8 women, age 42 ± 11 years, HbA1c 59 ± 8 mmol/mol (7.6 ± 0.8%)); 60-min moderate-intensity cycle ergometer exercise; capillary reference blood glucose (EKF S-Line)
Participants
22 people
Comparison
Real-time continuous glucose monitor (rtCGM) vs isCGM during exercise
Primary endpoint
Median Absolute Relative Difference (MedARD) vs capillary reference blood glucose
Follow-up
During exercise
Methodological detailshead-to-head comparison, simultaneous use of both CGM systems
  • Head-to-head comparison
  • Simultaneous use of both CGM systems

Primary result

As reported in the abstract

MedARD
GroupValueComparison points
rtCGMmedian 14.6% (IQR 7.0–23.8)2304
isCGMmedian 11.6% (IQR 5.6–19.6)2266

Value

rtCGMmedian 14.6% (IQR 7.0–23.8)
isCGMmedian 11.6% (IQR 5.6–19.6)

Comparison points

rtCGM2304
isCGM2266
  • rtCGM vs isCGM: P < 0.0001

Further findings

Median

OutcomertCGMisCGMP value
MedARD, TBR (<70 mg/dL) · during exercise39.2% (IQR 31.8–46.8)27.0% (IQR 17.0–34.6)P = 0.0001
MedARD, TIR (70-180 mg/dL) · during exercise16.1% (IQR 8.1–24.8)12.8% (IQR 6.4–20.4)P < 0.0001
MedARD, TAR (>180 mg/dL) · during exercise9.5% (IQR 4.7–16.0)8.0% (IQR 3.8–13.7)P = 0.0064

Original publication

Decision accuracy of simultaneously used real‐time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI ‐1 study. Diabet Med. Published 18 February 2026. doi:10.1111/dme.70267

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.